Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Osman Yilmaz, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Yilmaz O, Pinto K, Deshpande V. Navigating the Challenges Associated With a Diagnosis of Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis. Arch Pathol Lab Med. 2022 Sep 22. PMID: 36136300.
    Citations:    Fields:    
  2. Yilmaz O, Crabbe A, Neyaz A, Pankaj A, Lee SH, Hosseini S, Rickelt S, Cerda S, Zhao Q, Leijsen L, Dineaux A, Shroff SG, Crotty R, Zhang ML, Yilmaz OH, Patil DT, Berger D, Deshpande V. Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon. Histopathology. 2022 Sep; 81(3):380-388. PMID: 35789111.
    Citations:    Fields:    
  3. Yilmaz O, Pankaj A, Neyez A, Rickelt S, Taylor M, Lang ER, Leijsen L, Dinaux A, Shroff SG, Crotty R, Zhang ML, Cerda S, Zhao Q, Ferrone C, Ting DT, Patil DT, Yilmaz O, Berger D, Deshpande V. Programmed death-ligand 1 expression in the immune compartment of colon carcinoma. Mod Pathol. 2022 Nov; 35(11):1740-1748. PMID: 35773332.
    Citations:    Fields:    
  4. Neyaz A, Pankaj A, Crabbe A, Rickelt S, Leijssen L, Dinaux A, Taylor M, Shroff SG, Crotty R, Zhang ML, Yilmaz OH, Yilmaz O, Patil DT, Parikh AR, Ting DT, Berger D, Deshpande V. Correlation of clinical, pathologic, and genetic parameters with intratumoral immune milieu in mucinous adenocarcinoma of the colon. Mod Pathol. 2022 Nov; 35(11):1723-1731. PMID: 35590108.
    Citations:    Fields:    
  5. Arora KS, Anderson MA, Neyaz A, Yilmaz O, Pankaj A, Ferrone CR, Zen Y, England J, Deshpande V. Fibrohistiocytic Variant of Hepatic Pseudotumor: An Antibiotic Responsive Tumefactive Lesion. Am J Surg Pathol. 2021 10 01; 45(10):1314-1323. PMID: 34334689.
    Citations:    Fields:    Translation:Humans
  6. Brown NA, Plouffe KR, Yilmaz O, Weindorf SC, Betz BL, Carey TE, Seethala RR, McHugh JB, Tomlins SA, Udager AM. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol. 2021 06; 34(6):1133-1142. PMID: 33203919; PMCID: PMC8126579.
    Citations: 8     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yilmaz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (39)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.